Loading...
The effects of crizotinib in a transgenic Drosophila model expressing the human TPM4-ALK fusion gene or TPM4
Anaplastic lymphoma kinase (ALK) fusion events lead to constitutive activation of the ALK kinase domain, thereby functioning as oncogenic drivers. These fusion proteins have been identified in numerous cancers. Crizotinib, a small molecule inhibitor of c-Met and ALK, is a Food and Drug Administratio...
Na minha lista:
| Udgivet i: | Biol Open |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Company of Biologists Ltd
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6679403/ https://ncbi.nlm.nih.gov/pubmed/31278140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1242/bio.044362 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|